Long‐Term Outcomes of Liver Transplant Recipients. What Do Patients Die From?
- 8 May 2025
- journal article
- Published by Wiley in World Journal of Surgery
- Vol. 49 (6) , 1632-1642
Abstract
Background: Several advances in liver transplantation (LT) have provided an increased rate in 1‐year patient survival, currently reported between 84.5% and 91.4%. However, this significant improvement is not widely maintained after the 1‐year of follow‐up. In this study, we analyze short‐term and long‐term results in LT recipients. Methods: A retrospective observational cohort study, including patients who underwent LT between 1990 and 2009 and were followed for a minimum 15‐year period, analyzing the causes and risk factors of mortality and patient and graft survival from LT up to the last outpatient visit. Results: A total of 594 patients with LT were included (median age, 53‐year and 69.7% male). The most common indications for LT were HCV‐cirrhosis (267 patients), alcoholic cirrhosis (250 patients), and hepatocellular carcinoma (HCC) (144 patients). Post‐LT complications were acute rejection in 44.1%, cardiovascular in 40.6%, chronic kidney disease in 40.1%, hypertension in 22.6%, and de novo tumors in 25.6%. Retransplantation was performed in 40 (6.7%) patients. A total of 388 (65.3%) patients died during a follow‐up over 20 years: 106 (17.8%) in the first year post‐LT; 76 (12.8%) between 2 and 5 years; 75 (12.6%) between 6 and 10 years; 73 (812.3%) between 11 and 15 years; 30 (5%) between 16 and 20 years; and 28 (4.7%) after 20 years. The overall causes of death were infection in 69 (11.6%) patients, cardiovascular complications in 58 (9.8%) patients, pulmonary complications in 8 (1.3%) patients, liver graft failure in 126 (21.2%) patients, HCC recurrence in 15 (2.6%) patients, de novo tumors in 72 (12.1%) patients, and miscellaneous in 40 (6.7%) patients. Rates of actuarial patient survival at 1‐, 3‐, 5‐, 10‐, 15‐, and 20‐year after LT were 82.7%, 75.6%, 70%, 58.6%, 45.2%, and 37.6%, respectively, and actuarial graft survival were 80%, 72.5%, 67.1%, 54.8%, 42.6%, and 34.6%, respectively. Advanced recipient age, blood transfusion, and infection were the main risk factors for patient mortality. Conclusions: The highest mortality rate was within the first year of LT, and the most common causes of death were hepatic failure, de novo tumors, infection, cardiovascular disease, and HCC recurrence.Keywords
This publication has 44 references indexed in Scilit:
- OPTN/SRTR 2021 Annual Data Report: LiverAmerican Journal of Transplantation, 2023
- Long-term Care of the Adult Liver Transplant RecipientJournal of Clinical and Experimental Hepatology, 2022
- Safe use of livers from deceased donors older than 70 years in recipients with HCV cirrhosis treated with direct-action antivirals. Retrospective cohort studyInternational Journal of Surgery, 2021
- Short- and long-term mortality after liver transplantation in patients with and without hepatocellular carcinoma in the UKBritish Journal of Surgery, 2020
- Biliary Complications After Liver Transplantation From Uncontrolled Donors After Circulatory Death: Incidence, Management, and OutcomeLiver Transplantation, 2019
- Reduction in liver transplant wait‐listing in the era of direct‐acting antiviral therapyHepatology, 2016
- Liver transplantation in Australia and New ZealandLiver Transplantation, 2016
- Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR)Journal of Hepatology, 2012
- Smoking Behavior in Liver Transplant RecipientsLiver Transplantation, 2009
- Smoking-related morbidity and mortality following liver transplantationLiver Transplantation, 2008